faxvein.pages.dev









Kan mna få ms i tummarna

Signs and symptoms of multiple sclerosis

Neurological signs and symptoms

The signs and symptoms of multiple sclerosis (MS) encompass a bred range of neurological and physical manifestations, including framtidsperspektiv problems, muscle weakness, coordination difficulties, and cognitive impairment, varying significantly in severity and progression among individuals.

Multiple sclerosis can cause a variety of symptoms: changes in känsla (hypoesthesia), muscle weakness, abnormal muscle spasms, or difficulty moving; difficulties with coordination and balance; problems in speech (dysarthria) or swallowing (dysphagia), visual problems (nystagmus, optic neuritis, phosphenes or diplopia), fatigue and acute or chronic pain syndromes, bladder and bowel difficulties, cognitive impairment, or emotional symptomatology (mainly major depression).

Vissa infektioner

The main clinical measure in progression of the disability and severity of the symptoms fryst vatten the Expanded Disability ställning eller tillstånd Scale or EDSS.[1]

The första attacks are often transient, mild (or asymptomatic), and self-limited. They often do not prompt a health care visit and sometimes are only identified in retrospect once the diagnosis has been made after further attacks.

The most common första symptoms reported are: changes in känsla in the arms, legs or face (33%), complete or partial framtidsperspektiv loss (optic neuritis) (20%), weakness (13%), double framtidsperspektiv (7%), unsteadiness when walking (5%), and balance problems (3%); but many rare första symptoms have been reported such as aphasia or psychosis.[2][3] Fifteen percent of individuals have multiple symptoms when they first seek medical attention.[4]

Fatigue

[edit]

Fatigue fryst vatten very common[5] and disabling in MS.[6][7][8] Some 65% of people with MS experience fatigue symptomatology, and of these some 15-40% report fatigue as their most disabling MS symptom.[9] A 2023 study funnen that effect on fatigue was the most valued attribute of MS therapy, and that participants would accept six additional relapses in 2 years and a decrease of 7 years in time to disease progression to improve either cognitive or physical fatigue from "quite a bit of difficulty" to "no difficulty."[10]

The pathophysiology and mechanisms causing MS fatigue are not well understood.[11][12][13][14][excessive citations]

MS fatigue can be affected bygd body heat[15][16] and this may differentiate MS fatigue from other primary fatigue.[5][17][18][19][20][21][15][excessive citations]

Perceived fatigue and fatigability (loss of strength) are regarded independently.[22][23] Primary MS fatigue fryst vatten sometimes called "lassitude.'[24] MS fatigue may reduce during periods of other MS symptom remission.[25][26]

Primary vs.

secondary

[edit]

In some areas it has been proposed that fatigue be separated into primary fatigue, caused directly bygd a disease process, and secondary fatigue, caused bygd more general impacts on the individ of having a disease (such as disrupted sleep).[27][28][29][30][excessive citations]

Contributory factors to secondary fatigue

[edit]

Factors such as disturbed sova, chronic pain, poor nutrition, or even some medications can all contribute to secondary fatigue and medical professionals are encouraged to identify and modify them.[31]

Association with depression

[edit]

Early 2000s commentary saw a close relationship of secondary fatigue with depressive symptomatology.[32] When nedstämdhet fryst vatten reduced fatigue also tends to reduce and it fryst vatten recommended that patients should be evaluated for nedstämdhet before other therapeutic approaches are used.[33]

Correlation with brain changes

[edit]

Studies have funnen MS fatigue correlates, not with skada volume or brain atrophy, but with damage to NAWM (normal appearing vit matter) (which will not show on normal MRI but will show on DTI (diffusion tensor imaging)).[34][35][36][37][38][39] The correlation becomes unreliable due to ageing in patients aged over 65.[40]

A 2008 study funnen MS fatigue correlated with skada load and brain atrophy.[41]

A 2024 study funnen results suggested that fatigue was not driven bygd neuroinflammation or neurodegeneration measurable bygd current structural MRI in early RRMS.[42]

Medications

[edit]

Medications used to treat MS fatigue include amantadine,[43][44]pemoline,[45][46]methylphenidate, and modafinil,[47] as well as cognitive behavioral therapy (CBT) and psychological interventions of energy conservation;[48][49] but their effects are limited.[47] For these reasons fatigue fryst vatten a difficult symptom to manage.

Technology

[edit]

Apps are being experimented with in the field of MS fatigue.[50]

Bladder and bowel

[edit]

Bladder problems (See also urinary struktur and urination) appear in 70–80% of people with multiple sclerosis (MS) and they have an important effect both on hygiene habits and social activity.[51][52] Bladder problems are usually related with high levels of disability and pyramidal signs in lower limbs.[53]

The most common problems are an increase in frequency and urgency (incontinence) but difficulties to begin urination, hesitation, leaking, känsla of incomplete urination, and retention also appear.

When retention occurs secondary urinary infections are common.

There are many cortical and subcortical structures implicated in urination[54] and MS lesions in various huvud nervous struktur structures can cause these kinds of symptoms.

Treatment objectives are the alleviation of symptoms of urinary dysfunction, treatment of urinary infections, reduction of complicating factors and the preservation of renal function.

Treatments can be classified in two main subtypes: pharmacological and non-pharmacological. Pharmacological treatments vary greatly depending on the ursprung or type of dysfunction and some examples of the medications used are:[55]alfuzosin for retention,[56]trospium and flavoxate for urgency and incontinency,[57][58] and desmopressin for nocturia.[59][60] Non pharmacological treatments involve the use of pelvic floor muscle training, stimulation, biofeedback, pessaries, bladder retraining, and sometimes intermittent catheterization.[61][62]

Bowel problems affect around 70% of patients.

Around 50% of patients experience constipation and up to 30% experience fecal incontinence.[62] Cause of bowel impairments in MS patients fryst vatten usually either a reduced gut motility or an impairment in neurological control of defecation. The former fryst vatten commonly related to immobility or secondary effects from drugs used in the treatment of the disease.[62] Pain or problems with defecation can be helped with a diet change which includes among other changes an increased fluid intake, oral laxatives or suppositories and enemas when habit changes and oral measures are not enough to control the problems.[62][63]

Cognitive deficits (cog-fog)

[edit]

Deficits

[edit]

Some of the most common deficits affect recent memory, attention, processing speed, visual-spatial abilities and executive function.[64][14] Symptoms related to cognition include emotional instability and fatigue including neurological fatigue.

Cognitive deficits are independent of physical disability and can occur in the absence of neurological dysfunction.[65]

Appraisal

[edit]

Reviews have recommended annual appraisal using the tecken Digit Modalities Test (SDMT) or similarly validated test.[66][67][68]

Effects

[edit]

Severe cognitive impairment fryst vatten a major predictor of a low quality of life, unemployment, caregiver distress,[69] and difficulty in driving;[70] limitations in a patient's social and work activities are also correlated with the extent of impairment.[65]

Prevalence

[edit]

Cognitive impairments occur in about 40 to 60 percent of patients with multiple sclerosis,[71][72][67] with the lowest percentages usually from community-based studies and the highest ones from hospital-based.

Impairments may be present at the beginning of the disease.[73] Probable multiple sclerosis patients, meaning after a first attack but before a secondary confirmatory one, have up to 50 percent of patients with impairment at onset.[74]Dementia fryst vatten rare and occurs in only fem percent of patients.[65]

Causation

[edit]

Cognitive deficits have been linked to greater lesion load, vit matter skada location, microstructural injury, gray matter lesions, cortical and subcortical gray matter brain atrophy, and discrepant patterns of cerebral activation.[68] Measures of tissue atrophy are well correlated with, and predict, cognitive dysfunction.

Neuropsychological outcomes are highly correlated with linear measures of sub-cortical atrophy. Cognitive impairment fryst vatten the result of not only tissue damage,[75] but tissue repair and adaptive functional reorganization.[69]

Postulated treatments

[edit]

As of 2018 efficacy of possible interventions was low, inconclusive, or preliminary.[68]Neuropsychological rehabilitation may help to reverse or decrease the cognitive deficits although studies on the issue have been of low quality.[76]Acetylcholinesterase inhibitors are commonly used to treat Alzheimer's disease related dementia and so are thought to have potential in treating the cognitive deficits in multiple sclerosis.

They have been funnen to be effective in preliminary clinical trials.[76]

Prevention

[edit]

Primary prevention bygd interventions and healthy lifestyles that promote brain maintenance has been proposed.[68]

Emotional

[edit]

Emotional symptoms are also common and are thought to be both a normal response to having a debilitating disease and the result of damage to specific areas of the huvud nervous struktur that generate and control emotions.[citation needed]

Clinical nedstämdhet fryst vatten the most common neuropsychiatric condition: lifetime nedstämdhet prevalence rates of 40–50% and 12-month prevalence rates around 20% have been typically reported for samples of people with MS; these figures are considerably higher than those for the general population or for people with other chronic illnesses.[77][78] Brain imaging studies ansträngande to relate nedstämdhet to lesions in certain regions of the brain have met with variabel success.

On balance the bevis seems to favour an association with neuropathology in the left anterior temporal/parietal regions.[79]

Other feelings such as anger, anxiety, frustration, and hopelessness also appear frequently. Suicide fryst vatten a possibility, since it accounts for 15% of MS deaths.[80]

Rarely psychosis may also be featured.[81]

Internuclear ophthalmoplegia

[edit]

Main article: Internuclear ophthalmoplegia

Internuclear ophthalmoplegia fryst vatten a disorder of conjugate sidledes gaze.

The affected eye shows impairment of adduction. The partner eye diverges from the affected eye during abduction, producing diplopia; during extreme abduction, compensatory nystagmus can be seen in the partner eye. Diplopia means double framtidsperspektiv while nystagmus fryst vatten involuntary eye movement characterized bygd alternating smooth pursuit in one direction and a saccadic movement in the other direction.[citation needed]

Internuclear ophthalmoplegia occurs when MS affects a part of the brain stem called the medial longitudinal fasciculus, which fryst vatten responsible for communication between the two eyes bygd connecting the abducens nucleus of one side to the oculomotor nucleus of the opposite side.

This results in the failure of the medial rectus muscle to contract appropriately, so that the eyes do not move equally (called disconjugate gaze).[citation needed]

Different drugs as well as optic compensatory systems and prisms can be used to improve these symptoms.[82][83][84][85] Surgery can also be used in some cases for this problem.[86]

Mobility restrictions

[edit]

Restrictions in mobility (walking, transfers, bed mobility etc.) are common in individuals with multiple sclerosis.

Although this fryst vatten not something constant it can happen when experiencing a flare up. Within 10 years after the onset of MS one-third of patients reach a score of 6 on the Expanded Disability ställning eller tillstånd Scale (EDSS), requiring the use of a unilateral walking aid, and bygd 30 years the proportion increases to 83%. Within fem years of onset the EDSS fryst vatten six in 50% of those with the progressive form eller gestalt of MS.[87]

A bred range of impairments may exist in people with MS, which can act either alone or in combination to impact directly on a person's balance, function and mobility.

Such impairments include fatigue, weakness, hypertonicity, low exercise tolerance, impaired balance, ataxia and tremor.[88]

Interventions may be aimed at the individual impairments that reduce mobility or at the level of disability. This second level intervention includes arvode, education, and instruction in the use of utrustning such as walking aids, wheelchairs, motorized scooters and bil adaptations as well as instruction on compensatory strategies to accomplish an activity — for example åtagande safe transfers bygd pivoting in a flexed posture rather than standing up and stepping around.

Optic neuritis

[edit]

Main article: Optic neuritis

Up to 50% of patients with MS will develop an episode of optic neuritis and 20% of the time optic neuritis fryst vatten the presenting sign of MS. The presence of demyelinating vit matter lesions on brain MRIs at the time of föredrag for optic neuritis fryst vatten the strongest predictor in developing clinical diagnosis of MS.

Almost half of patients with optic neuritis have vit matter lesions consistent with multiple sclerosis.

At fem year follow-ups the overall fara of developing MS fryst vatten 30%, with or without MRI lesions. Patients with a normal MRI still develop MS (16%), but at a lower rate compared to those patients with three or more MRI lesions (51%).

From the other perspective, however, 44% of patients with any demyelinating lesions on MRI at framställning will not have developed MS ten years later.[89][90]

Individuals experience rapid onset of pain in one eye followed bygd suddig framtidsperspektiv in part or all its visual field. Flashes of light (phosphenes) may also be present.[91]Inflammation of the optic nerve causes loss of framtidsperspektiv most usually bygd the swelling and destruction of the myelin sheath covering the optic nerve.

The blurred framtidsperspektiv usually resolves within 10 weeks but individuals are often left with less levande color framtidsperspektiv, especially red, in the affected eye.[citation needed]

A systemic intravenous treatment with corticosteroids may quicken the healing of the optic nerve, prevent complete loss of framtidsperspektiv and delay the onset of other symptoms.[citation needed]

Asymmetry in thickness of RNFL as indicator of optic neuritis in MS

[edit]

Asymmetry between the eyes in thickness of RNFL has been proposed as a strong indicator of optic neuritis in MS.[92][93][94] RNFL uppgifter may indikera the pace of future development of the MS.[95][96]

Pain

[edit]

Pain fryst vatten a common symptom in MS.

A recent study systematically pooling results from 28 studies (7101 patients) estimates that pain affects 63% of people with MS.[97] These 28 studies described pain in a large range of different people with MS. The authors funnen no bevis that pain was more common in people with progressive types of MS, in females compared to males, in people with different levels of disability, or in people who had had MS for different periods of time.

Pain can be severe and debilitating, and can have a profound effect on the quality of life and mental health of those affected.[98] Certain types of pain are thought to sometimes appear after a lesion to the ascending or descending tracts that control the transmission of painful stimulus, such as the anterolateral struktur, but many other causes are also possible.[84] The most prevalent types of pain are thought to be headaches (43%), dysesthetic limb pain (26%), back pain (20%), painful spasms (15%) such as the MS Hug,[99] painful Lhermitte's phenomenon (16%) and Trigeminal Neuralgia (3%).[97] These authors did not however find enough information to quantify the prevalence of painful optic neuritis.

Acute pain fryst vatten mainly due to optic neuritis, trigeminal neuralgia, Lhermitte's sign or dysesthesias.[100]Subacute pain fryst vatten usually secondary to the disease and can be a consequence of spending too much time in the same position, urinary retention, or infected skin ulcers. Chronic pain fryst vatten common and harder to treat.[citation needed]

Trigeminal neuralgia

[edit]

Trigeminal neuralgia (or "tic douloureux") fryst vatten a disorder of the trigeminal nerve that causes episodes of intense pain in the eyes, lips, nose, scalp, forehead, and jaw, affecting 2-4% of MS patients.[97] The episodes of pain occur paroxysmally (suddenly) and the patients describe it as trigger area on the face, so sensitive that touching or even air currents can bring an episode of pain.

Usually it fryst vatten successfully treated with anticonvulsants such as carbamazepine,[101] or phenytoin[102] although others such as gabapentin[103] can be used.[104] When drugs are not effective, surgery may be recommended. Glycerol rhizotomy (surgical injection of glycerol into a nerve) has been studied[105] although the beneficial effects and risks in MS patients of the procedures that relieve pressure on the nerve are still beneath discussion.[106][107]

Lhermitte's sign

[edit]

Lhermitte's sign fryst vatten an electrical känsla that runs down the back and into the limbs and fryst vatten produced bygd bending the neck forward.

The sign suggests a skada of the dorsal columns of the cervical cord or of the svansrelaterad medulla, correlating significantly with cervical MRI abnormalities.[108] Between 25 and 40% of MS patients report having Lhermitte's sign during the course of their illness.[109][110][111] It fryst vatten not always experienced as painful, but about 16% of people with MS will experience painful Lhermitte's sign.[97]

Dysesthesias

[edit]

Dysesthesias are disagreeable sensations produced bygd ordinary stimuli.

The abnormal sensations are caused bygd lesions of the peripheral or huvud sensory pathways, and are described as painful feelings such as burning, wetness, itching, electric chock or pins and needles.

Neurogen eller neuropatisk smärta

Both Lhermitte's sign and painful dysesthesias usually respond well to treatment with carbamazepine, clonazepam or amitriptyline.[112][113][114] A related symptom fryst vatten a pleasant, yet unsettling känsla which has no normal explanation (such as känsla of gentle warmth arising from touch bygd clothing)[citation needed]

Reduced sense of smell

[edit]

People with Multiple Sclerosis have been funnen to have reduced sense of smell, including lower olfactory thresholds.[115][116][117]

Sexual

[edit]

Sexual dysfunction (SD) fryst vatten one of many symptoms affecting persons with a diagnosis of MS.

SD in dock encompasses both erectile and ejaculatory disorder. The prevalence of SD in dock with MS ranges from 75 to 91%.[118] Erectile dysfunction appears to be the most common form eller gestalt of SD documented in MS. SD may be due to alteration of the ejaculatory reflex which can be affected bygd neurological conditions such as MS.[118] sexuell dysfunction fryst vatten also prevalent in kvinna MS patients, typically lack of orgasm, probably related to disordered genital känsla.

Spasticity

[edit]

Spasticity fryst vatten characterized bygd increased stiffness and slowness in limb movement, the development of certain postures, an association with weakness of voluntary muscle power, and with involuntary and sometimes painful spasms of limbs.[31] Painful spasms affect about 15% of people with MS overall.[97] A physiotherapist can help to reduce spasticity and avoid the development of contractures with techniques such as passive stretching.[119] There fryst vatten bevis, albeit limited, of the clinical effectiveness of THC and CBD extracts,[120]baclofen,[121]dantrolene,[122]diazepam,[123] and tizanidine.[124][125][126] In the most complicated cases intrathecal injections of baclofen can be used.[127] There are also palliative measures like castings, splints or customized seatings.[31]

Speech and swallowing

[edit]

Speech problems include slurred speech, low tone of röst (dysphonia), decreased talking speed, and problems with articulation of sounds (dysarthria).

A related bekymmer, since it involves similar anatomical structures, fryst vatten swallowing difficulties (dysphagia).[128]

Transverse myelitis

[edit]

Main article: Transverse myelitis

Some MS patients develop rapid onset of numbness, weakness, bowel or bladder dysfunction, and/or loss of muscle function, typically in the lower half of the body.[citation needed] This fryst vatten the result of MS attacking the spinal cord.

The symptoms and signs depend upon the nerve cords involved and the extent of the involvement.

Prognosis for complete recovery fryst vatten generally poor. Recovery from transverse myelitis usually begins between weeks 2 and 12 following onset and may continue for up to 2 years in some patients and as many as 80% of individuals with transverse myelitis are left with lasting disabilities.[citation needed]

Though it was considered for many years that traverse myelitis was a normal consequence of MS, since the upptäckt of anti-AQP4 and anti-MOG biomarkers it fryst vatten not.

Now TM fryst vatten considered an indicator of neuromyelitis optica, and a red flag against the diagnosis of MS.[129]

Tremor and ataxia

[edit]

Main article: Tremor

Tremor fryst vatten an unintentional, somewhat rhythmic, muscle movement involving to-and-fro movements (oscillations) of one or more parts of the body. It fryst vatten the most common of all involuntary movements and can affect the hands, arms, head, face, vocal cords, trunk, and legs.

Ataxia fryst vatten an unsteady and clumsy motion of the limbs or torso due to a failure of the gross coordination of muscle movements. People with ataxia experience a failure of muscle control in their arms and legs, resulting in a lack of balance and coordination or a disturbance of gångart.

Tremor and ataxia are frequent in MS and present in 25 to 60% of patients.

They can be very disabling and embarrassing, and are difficult to manage.[130] The ursprung of tremor in MS fryst vatten difficult to identify but it can be due to a mixture of different factors such as damage to the cerebellar connections, weakness, spasticity, etc.

Many medications have been proposed to treat tremor; however their efficacy fryst vatten very limited.

Medications that have been reported to provide some relief are isoniazid,[131][132][133][134]carbamazepine,[101]propranolol[135][136][137] and gluthetimide[138] but published bevis of effectiveness fryst vatten limited.[139]Physical therapy fryst vatten not indicated as a treatment for tremor or ataxia although the use of orthese devices can help.

An example fryst vatten the use of wrist bandages with weights, which can be useful to increase the inertia of movement and therefore reduce tremor.[140] daglig use objects are also adapted so they are easier to grab and use.

If all these measures fail patients are candidates for thalamussurgery. This kind of surgery can be both a thalamotomy or the implantation of a thalamic stimulator.

Complications are frequent (30% in thalamotomy and 10% in deep brain stimulation) and include a worsening of ataxia, dysarthria and hemiparesis. Thalamotomy fryst vatten a more efficacious surgical treatment for intractable MS tremor though the higher incidence of persistent neurological deficits in patients receiving lesional surgery supports the use of deep brain stimulation as the preferred surgical strategy.[141]

Sleep disturbance

[edit]

Around half of people with MS säga they experience disturbed sova.

sova disturbance fryst vatten not regarded as a primary effect of the MS disease itself. Rather it fryst vatten regarded as a secondary effect resulting from other factors that are themselves caused or exacerbated bygd MS, such as spasms, pain, anxiety, nedstämdhet and high caffeine intake.[142][143][144][145][146][147]

MS fatigue has been funnen to not correlate with sova duration, but there was some correlation with insomnia and sova quality.[148] It may be that primary MS fatigue fryst vatten unaffected bygd sova characteristics, but that sova deprivation correlates with secondary MS fatigue.[149]

CPAP treatment in patients with MS and sova apnea may reduce fatigue and improve the physical quality of life.[150]

References

[edit]

  1. ^Kurtzke JF (November 1983).

    "Rating neurologic impairment in multiple sclerosis: an expanded disability ställning eller tillstånd scale (EDSS)". Neurology. 33 (11): 1444–1452. doi:10.1212/WNL.33.11.1444. PMID 6685237.

  2. ^Navarro S, Mondéjar-Marín B, Pedrosa-Guerrero A, Pérez-Molina inom, Garrido-Robres JA, Alvarez-Tejerina A (2005). "[Aphasia and parietal syndrome as the presenting symptoms of a demyelinating disease with pseudotumoral lesions]".

    Revista dem Neurologia. 41 (10): 601–603. PMID 16288423.

  3. ^Jongen PJ (June 2006). "Psychiatric onset of multiple sclerosis". Journal of the Neurological Sciences. 245 (1–2): 59–62. doi:10.1016/j.jns.2005.09.014. PMID 16631798. S2CID 33098365.
  4. ^Paty D, Studney D, Redekop K, Lublin F (1994).

    "MS COSTAR: a computerized patient record adapted for clinical research purposes". Annals of Neurology. 36 (Suppl): S134–S135. doi:10.1002/ana.410360732. PMID 8017875. S2CID 23425667.

  5. ^ ab"Fatigue". mstrust.org.uk.
  6. ^"Fatigue". Letchworth Garden City, United Kingdom: Multiple Sclerosis Trust.
  7. ^Moore H, Nair KP, Baster K, Middleton R, Paling D, Sharrack B (August 2022).

    "Fatigue in multiple sclerosis: A UK MS-register based study". Multiple Sclerosis and Related Disorders. 64: 103954. doi:10.1016/j.msard.2022.103954. PMID 35716477.

  8. ^Hubbard AL, Golla H, Lausberg H (June 2021). "What's in a name? That which we call Multiple Sclerosis Fatigue". Multiple Sclerosis. 27 (7): 983–988.

    doi:10.1177/1352458520941481.

    Ditt kön

    PMC 8142120. PMID 32672087.

  9. ^Bakalidou D, Giannopapas V, Giannopoulos S (July 2023). "Thoughts on Fatigue in Multiple Sclerosis Patients". Cureus. 15 (7): e42146. doi:10.7759/cureus.42146. PMC 10438195. PMID 37602098.
  10. ^Tervonen T, Fox RJ, Brooks A, Sidorenko T, Boyanova N, Levitan B, et al.

    (2023). "Treatment preferences in relation to fatigue of patients with relapsing multiple sclerosis: A discrete choice experiment". Multiple Sclerosis Journal: Experimental, Translational and Clinical.

    MS är en sjukdom i det centrala nervsystemet, det vill säga hjärnan och ryggmärgen

    9 (1): 20552173221150370. doi:10.1177/20552173221150370. PMC 9880588. PMID 36714174.

  11. ^Manjaly ZM, Harrison NA, Critchley HD, Do CT, Stefanics G, Wenderoth N, et al. (June 2019). "Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis". Journal of Neurology, Neurosurgery, and Psychiatry.

    90 (6): 642–651. doi:10.1136/jnnp-2018-320050. PMC 6581095. PMID 30683707.

  12. ^Ellison PM, Goodall S, Kennedy N, Dawes H, Clark A, Pomeroy V, et al. (September 2022). "Neurostructural and Neurophysiological Correlates of Multiple Sclerosis Physical Fatigue: Systematic Review and Meta-Analysis of Cross-Sectional Studies".

    Neuropsychology Review. 32 (3): 506–519. doi:10.1007/s11065-021-09508-1. PMC 9381450. PMID 33961198.

  13. ^Newland P, Starkweather A, Sorenson M (July 2016). "Central fatigue in multiple sclerosis: a review of the literature". The Journal of Spinal Cord Medicine. 39 (4): 386–399. doi:10.1080/10790268.2016.1168587.

    PMC 5102292. PMID 27146427.

  14. ^ abChen MH, Wylie GR, Sandroff BM, Dacosta-Aguayo R, DeLuca J, Genova HM (August 2020).

    Två typer av smärta vid MS

    "Neural mechanisms underlying state mental fatigue in multiple sclerosis: a pilot study". Journal of Neurology. 267 (8): 2372–2382. doi:10.1007/s00415-020-09853-w. PMID 32350648.

  15. ^ abChristogianni A, O'Garro J, Bibb R, Filtness A, Filingeri D (November 2022). "Heat and cold sensitivity in multiple sclerosis: A patient-centred perspective on triggers, symptoms, and thermal resilience practices".

    Multiple Sclerosis and Related Disorders. 67: 104075. doi:10.1016/j.msard.2022.104075. PMID 35963205.

  16. ^Davis SL, efternamn bladte, vit AT, Frohman EM (November 2010). "Thermoregulation in multiple sclerosis". Journal of Applied Physiology. 109 (5): 1531–1537. doi:10.1152/japplphysiol.00460.2010. PMC 2980380.

    PMID 20671034.

  17. ^"Heat Sensitivity". Archived from the original on 2024-01-17. Retrieved 2024-03-15.
  18. ^Trust MS. "Temperature sensitivity | MS Trust". mstrust.org.uk. Archived from the original on 2024-01-17. Retrieved 2024-03-15.
  19. ^"Temperature sensitivity".

    mstrust.org.uk. Archived from the original on 2024-01-17. Retrieved 2024-03-15.

  20. ^Sumowski JF, Leavitt VM (July 2014). "Body temperature fryst vatten elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure". Archives of Physical medicin and Rehabilitation.

    95 (7): 1298–1302. doi:10.1016/j.apmr.2014.02.004. PMC 4071126.

    PMID 24561056.

  21. ^Leavitt VM, dem Meo E, Riccitelli G, Rocca MA, Comi G, Filippi M, et al. (November 2015). "Elevated body temperature fryst vatten linked to fatigue in an Italian sample of relapsing-remitting multiple sclerosis patients". Journal of Neurology. 262 (11): 2440–2442. doi:10.1007/s00415-015-7863-8.

    Faktorer som ökar risken att få MS är bland annat: Din ålder

    PMID 26223805.

  22. ^Loy BD, Taylor RL, Fling BW, Horak FB (September 2017). "Relationship between perceived fatigue and performance fatigability in people with multiple sclerosis: A systematic review and meta-analysis". Journal of Psychosomatic Research. 100: 1–7. doi:10.1016/j.jpsychores.2017.06.017. PMC 5875709.


  23. kan mna  ett fåtal ms  inom tummarna

  24. PMID 28789787.

  25. ^Patejdl R, Zettl UK (2022). "The pathophysiology of motor fatigue and fatigability in multiple sclerosis". Frontiers in Neurology. 13: 891415. doi:10.3389/fneur.2022.891415. PMC 9363784. PMID 35968278.
  26. ^"Empowering people affected bygd MS to live their best lives".

    National Multiple Sclerosis Society.

  27. ^"Fatigue in Patients With Multiple Sclerosis". Practical Neurology.
  28. ^"Relapsing remitting MS (RRMS)". mssociety.org. Retrieved 2024-04-23.
  29. ^"Fatigue in Patients with Multiple Sclerosis".
  30. ^Chalah MA, Riachi N, Ahdab R, Créange A, Lefaucheur JP, Ayache SS (2015).

    "Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation". Frontiers in Cellular Neuroscience. 9: 460. doi:10.3389/fncel.2015.00460. PMC 4663273. PMID 26648845.

  31. ^Gerber LH, Weinstein AA, Mehta R, Younossi ZM (July 2019). "Importance of fatigue and its measurement in chronic liver disease".

    World Journal of Gastroenterology. 25 (28): 3669–3683. doi:10.3748/wjg.v25.i28.3669. PMC 6676553. PMID 31391765.

  32. ^Hartvig Honoré P (June 2013). "Fatigue". European Journal of Hospital Pharmacy. 20 (3): 147–148. doi:10.1136/ejhpharm-2013-000309. S2CID 220171226.
  33. ^ abcThe Royal College of Physicians (2004).

    Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care(PDF). Salisbury, Wiltshire: Sarum ColourView Group. ISBN .

  34. ^Bakshi R (June 2003). "Fatigue associated with multiple sclerosis: diagnosis, impact and management". Multiple Sclerosis.

    9 (3): 219–227. doi:10.1191/1352458503ms904oa. PMID 12814166. S2CID 40931716.

  35. ^Mohr DC, Hart SL, Goldberg A (2003). "Effects of treatment for nedstämdhet on fatigue in multiple sclerosis". Psychosomatic Medicine. 65 (4): 542–547. CiteSeerX 10.1.1.318.5928. doi:10.1097/01.PSY.0000074757.11682.96. PMID 12883103. S2CID 16239318.
  36. ^Palotai M, Guttmann CR (June 2020).

    "Brain anatomical correlates of fatigue in multiple sclerosis". Multiple Sclerosis. 26 (7): 751–764. doi:10.1177/1352458519876032. PMID 31536461.

  37. ^Camera V, Mariano R, Messina S, Menke R, Griffanti L, Craner M, et al. (2023). "Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease".

    Brain Communications. 5 (3): fcad107. doi:10.1093/braincomms/fcad107. PMC 10171455. PMID 37180990.

  38. ^Preziosa P, Rocca MA, Pagani E, Valsasina P, Amato MP, Brichetto G, et al. (March 2023). "Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis".

    Journal of Neurology. 270 (3): 1543–1563. doi:10.1007/s00415-022-11486-0. hdl:10026.1/20405. PMID 36436069.

  39. ^Novo AM, Batista S, Alves C, d'Almeida OC, Marques IB, Macário C, et al. (December 2018). "The neural grund of fatigue in multiple sclerosis: A multimodal MRI approach". Neurology.

    Clinical Practice. 8 (6): 492–500. doi:10.1212/CPJ.0000000000000545. PMC 6294533. PMID 30588379.

  40. ^Bisecco A, Caiazzo G, d'Ambrosio A, en mjuk sittsäck fylld med små plastkulor R, Bonavita S, Docimo R, et al. (November 2016). "Fatigue in multiple sclerosis: The contribution of occult vit matter damage". Multiple Sclerosis.

    22 (13): 1676–1684. doi:10.1177/1352458516628331. PMID 26846989.

  41. ^Rocca MA, Parisi L, Pagani E, Copetti M, Rodegher M, Colombo B, et al. (November 2014). "Regional but not global brain damage contributes to fatigue in multiple sclerosis". Radiology. 273 (2): 511–520. doi:10.1148/radiol.14140417.

    PMID 24927473.

  42. ^Muñoz Maniega S, Chappell FM, Valdés Hernández MC, Armitage PA, Makin SD, Heye AK, et al. (February 2017). "Integrity of normal-appearing vit matter: Influence of age, visible sår burden and hypertension in patients with small-vessel disease". Journal of Cerebral Blood Flow and Metabolism. 37 (2): 644–656.

    doi:10.1177/0271678X16635657. PMC 5381455. PMID 26933133.

  43. ^Sepulcre J, Masdeu JC, Goñi J, Arrondo G, Vélez dem Mendizábal N, Bejarano B, et al. (March 2009). "Fatigue in multiple sclerosis fryst vatten associated with the disruption of frontal and parietal pathways". Multiple Sclerosis.

    15 (3): 337–344. doi:10.1177/1352458508098373. PMID 18987107. S2CID 2701289.

  44. ^https://academic.oup.com/braincomms/article/6/5/fcae278/7733609
  45. ^Pucci E, Branãs P, D'Amico R, Giuliani G, Solari A, Taus C (January 2007).

    Om du har nära genetiska släktingar med MS har du högre risk att utveckla sjukdomen

    Pucci E (ed.). "Amantadine for fatigue in multiple sclerosis". The Cochrane Database of Systematic Reviews. 2007 (1): CD002818. doi:10.1002/14651858.CD002818.pub2. PMC 6991937. PMID 17253480.

  46. ^"Amantadine". Medline. US National Library of medicin. April 2003. Retrieved 7 October 2007.
  47. ^Weinshenker BG, Penman M, Bass B, Ebers GC, Rice GP (August 1992).

    "A double-blind, randomized, crossover rättegång of pemoline in fatigue associated with multiple sclerosis". Neurology. 42 (8): 1468–1471. doi:10.1212/wnl.42.8.1468. PMID 1641137. S2CID 41990406.

  48. ^"Pemoline". Medline. US National Library of medicin. January 2006. Retrieved 7 October 2007.
  49. ^ ab"Comparing Treatments for Multiple Sclerosis-Related Fatigue - bevis Update for Clinicians | PCORI".

    www.pcori.org. 2023-09-01. Retrieved 2023-11-30.

  50. ^Mathiowetz VG, Finlayson ML, Matuska KM, Chen HY, Luo P (October 2005). "Randomized controlled rättegång of an energy conservation course for persons with multiple sclerosis". Multiple Sclerosis. 11 (5): 592–601. doi:10.1191/1352458505ms1198oa